{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:40:49Z","timestamp":1789533649690,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jcf.2019.08.010","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T04:53:59Z","timestamp":1572756839000},"page":"S82-S87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"S2","title":["Growth failure and treatment in cystic fibrosis"],"prefix":"10.1016","volume":"18","author":[{"given":"Trang N.","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Anabtawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7655-8954","authenticated-orcid":false,"given":"Melissa S.","family":"Putman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin","family":"Tangpricha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Stalvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jcf.2019.08.010_bb0005","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0002-8223(01)00113-4","article-title":"Stature as a prognostic factor in cystic fibrosis survival","volume":"101","author":"Beker","year":"2001","journal-title":"J Am Diet Assoc"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.010_bb0010","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1067\/mpd.2003.152","article-title":"Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis","volume":"142","author":"Konstan","year":"2003","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.010_bb0015","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1542\/peds.2007-3089","article-title":"Wisconsin cystic fibrosis neonatal screening G. recovery of birth weight z score within 2 years of diagnosis is positively associated with pulmonary status at 6 years of age in children with cystic fibrosis","volume":"123","author":"Lai","year":"2009","journal-title":"Pediatrics."},{"issue":"7","key":"10.1016\/j.jcf.2019.08.010_bb0020","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ppul.23715","article-title":"Risk factors for mortality before age 18 years in cystic fibrosis","volume":"52","author":"McColley","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.010_bb0025","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jpeds.2012.08.040","article-title":"Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis","volume":"162","author":"Yen","year":"2013","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.010_bb0030","first-page":"246","article-title":"Consensus report on nutrition for pediatric patients with cystic fibrosis","volume":"35","author":"Borowitz","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.010_bb0035","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.clnu.2012.08.017","article-title":"Stunting is an independent predictor of mortality in patients with cystic fibrosis","volume":"32","author":"Vieni","year":"2013","journal-title":"Clin Nutr"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.010_bb0040","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/ejcn.2013.20","article-title":"Nutritional care in children with cystic fibrosis: are our patients becoming better?","volume":"67","author":"Gaskin","year":"2013","journal-title":"Eur J Clin Nutr"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.010_bb0045","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jamapediatrics.2017.0206","article-title":"Effects of diagnosis by newborn screening for cystic fibrosis on weight and length in the first year of life","volume":"171","author":"Leung","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jcf.2019.08.010_bb0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1542\/peds.2015-2907","article-title":"Wisconsin cystic fibrosis neonatal screening G. pubertal height growth and adult height in cystic fibrosis after newborn screening","volume":"137","author":"Zhang","year":"2016","journal-title":"Pediatrics."},{"key":"10.1016\/j.jcf.2019.08.010_bb0055","series-title":"Annual data report to the center directors","first-page":"2018","author":"Cystic Fibrosis Foundation Patient Registry","year":"2017"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.010_bb0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jcf.2016.11.005","article-title":"BMI fails to identify poor nutritional status in stunted children with CF","volume":"16","author":"Konstan","year":"2017","journal-title":"J Cyst Fibros"},{"issue":"12","key":"10.1016\/j.jcf.2019.08.010_bb0065","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1210\/jc.2007-0526","article-title":"The somatomedin hypothesis 2007: 50 years later","volume":"92","author":"Kaplan","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.010_bb0070","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3476(85)80501-1","article-title":"Clinical longitudinal standards for height and height velocity for north American children","volume":"107","author":"Tanner","year":"1985","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.010_bb0075","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1054-139X(02)00485-8","article-title":"Growth at puberty","volume":"31","author":"Rogol","year":"2002","journal-title":"J Adolesc Health"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.010_bb0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ppul.21001","article-title":"Growth and long-term lung function in cystic fibrosis: a longitudinal study of patients diagnosed by neonatal screening","volume":"44","author":"Assael","year":"2009","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.010_bb0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/03014469400003242","article-title":"The adolescent growth spurt in children with cystic fibrosis","volume":"21","author":"Byard","year":"1994","journal-title":"Ann Hum Biol"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.010_bb0090","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/BF01958975","article-title":"Perspectives of longitudinal growth in cystic fibrosis from birth to adult age","volume":"153","author":"Haeusler","year":"1994","journal-title":"Eur J Pediatr"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.010_bb0095","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0022-3476(98)70024-1","article-title":"Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition","volume":"132","author":"Lai","year":"1998","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.010_bb0100","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/adc.77.6.497","article-title":"Height and weight in cystic fibrosis: a cross sectional study. UK Cystic Fibrosis Survey Management Committee","volume":"77","author":"Morison","year":"1997","journal-title":"Arch Dis Child"},{"issue":"22","key":"10.1016\/j.jcf.2019.08.010_bb0105","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM199011293232203","article-title":"The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508)","volume":"323","author":"Kerem","year":"1990","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jcf.2019.08.010_bb0110","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/adc.2006.107581","article-title":"Pancreatic phenotype in infants with cystic fibrosis identified by mutation screening","volume":"92","author":"Cipolli","year":"2007","journal-title":"Arch Dis Child"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.010_bb0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/j.1536-4801.2005.tb00964.x","article-title":"Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations","volume":"40","author":"Walkowiak","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.010_bb0120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1210\/er.2015-1026","article-title":"Growth and the growth hormone-insulin like growth factor 1 axis in children with chronic inflammation: current evidence, gaps in knowledge, and future directions","volume":"37","author":"Wong","year":"2016","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.010_bb0125","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/1099800416643585","article-title":"Growth deficiency in cystic fibrosis is observable at birth and predictive of early pulmonary function","volume":"18","author":"Darrah","year":"2016","journal-title":"Biol Res Nurs"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.010_bb0130","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jpeds.2005.04.031","article-title":"Gestational and neonatal characteristics of children with cystic fibrosis: a cohort study","volume":"147","author":"Festini","year":"2005","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.010_bb0135","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s004310051065","article-title":"Cystic fibrosis: a cause of reduced birth weight?","volume":"158","author":"Muller","year":"1999","journal-title":"Eur J Pediatr"},{"issue":"4","key":"10.1016\/j.jcf.2019.08.010_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175467","article-title":"Growth deficits in cystic fibrosis mice begin in utero prior to IGF-1 reduction","volume":"12","author":"Darrah","year":"2017","journal-title":"PLoS One."},{"issue":"5","key":"10.1016\/j.jcf.2019.08.010_bb0145","first-page":"250","article-title":"Insulin-like growth factor-1, leptin, body composition, and clinical status interactions in children with cystic fibrosis","volume":"67","author":"Boguszewski","year":"2007","journal-title":"Horm Res"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.010_bb0150","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/adc.72.6.494","article-title":"Diminished concentrations of insulin-like growth factor I in cystic fibrosis","volume":"72","author":"Laursen","year":"1995","journal-title":"Arch Dis Child"},{"issue":"47","key":"10.1016\/j.jcf.2019.08.010_bb0155","doi-asserted-by":"crossref","first-page":"20571","DOI":"10.1073\/pnas.1015281107","article-title":"Pigs and humans with cystic fibrosis have reduced insulin-like growth factor 1 (IGF1) levels at birth","volume":"107","author":"Rogan","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.jcf.2019.08.010_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188497","article-title":"Reduced bone length, growth plate thickness, bone content, and IGF-I as a model for poor growth in the CFTR-deficient rat","volume":"12","author":"Stalvey","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.010_bb0165","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0261-5614(92)90007-D","article-title":"Plasma insulin-like growth factor-I determinations in patients with cystic fibrosis: influence of the nutritional and liver status","volume":"11","author":"De Schepper","year":"1992","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.010_bb0170","first-page":"227","article-title":"Somatomedin activity in cystic fibrosis and reserpinized rats: possible explanation for growth retardation","volume":"10","author":"Lee","year":"1980","journal-title":"Ann Clin Lab Sci"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.010_bb0175","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0022-3476(81)80467-2","article-title":"Demonstration of normal plasma somatomedin concentrations in cystic fibrosis","volume":"99","author":"Rosenfeld","year":"1981","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.010_bb0180","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jcf.2012.08.003","article-title":"Growth retardation and reduced growth hormone secretion in cystic fibrosis. Clinical observations from three CF centers","volume":"12","author":"Ciro","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.jcf.2019.08.010_bb0185","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/thx.2006.075887","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone","volume":"62","author":"Shead","year":"2007","journal-title":"Thorax."},{"issue":"3","key":"10.1016\/j.jcf.2019.08.010_bb0190","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1203\/PDR.0b013e3181961e80","article-title":"Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation","volume":"65","author":"Pashuck","year":"2009","journal-title":"Pediatr Res"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.010_bb0195","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1677\/joe.1.06609","article-title":"The restricted potential for recovery of growth plate chondrogenesis and longitudinal bone growth following exposure to pro-inflammatory cytokines","volume":"189","author":"MacRae","year":"2006","journal-title":"J Endocrinol"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.010_bb0200","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0736-0266(00)00078-4","article-title":"Induction of apoptosis in chondrocytes by tumor necrosis factor-alpha","volume":"19","author":"Aizawa","year":"2001","journal-title":"J Orthop Res"},{"issue":"11","key":"10.1016\/j.jcf.2019.08.010_bb0205","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1359\/JBMR.040805","article-title":"Interleukin-1beta and TNF-alpha act in synergy to inhibit longitudinal growth in fetal rat metatarsal bones","volume":"19","author":"Martensson","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.010_bb0210","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1074\/jbc.275.6.3841","article-title":"Role of the suppressor of cytokine signaling-3 in mediating the inhibitory effects of interleukin-1beta on the growth hormone-dependent transcription of the acid-labile subunit gene in liver cells","volume":"275","author":"Boisclair","year":"2000","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.jcf.2019.08.010_bb0215","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.4049\/jimmunol.172.12.7713","article-title":"IL-1beta impairs insulin-like growth factor i-induced differentiation and downstream activation signals of the insulin-like growth factor i receptor in myoblasts","volume":"172","author":"Broussard","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.010_bb0220","first-page":"883","article-title":"The localization of the functional glucocorticoid receptor alpha in human bone","volume":"85","author":"Abu","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.010_bb0225","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrendo.2013.5","article-title":"Glucocorticoids and the regulation of growth hormone secretion","volume":"9","author":"Mazziotti","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"10.1016\/j.jcf.2019.08.010_bb0230","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1203229","article-title":"Effect of inhaled glucocorticoids in childhood on adult height","volume":"367","author":"Kelly","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jcf.2019.08.010_bb0235","article-title":"Inhaled corticosteroids in children with persistent asthma: effects on growth","author":"Zhang","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.jcf.2019.08.010_bb0240","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1515\/jpem-2017-0005","article-title":"Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function","volume":"30","author":"Terliesner","year":"2017","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.jcf.2019.08.010_bb0245","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/ppul.21127","article-title":"Growth in children with cystic fibrosis-related diabetes","volume":"44","author":"Cheung","year":"2009","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.010_bb0250","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11102-008-0105-7","article-title":"Growth hormone deficiency in children","volume":"11","author":"Richmond","year":"2008","journal-title":"Pituitary."},{"issue":"12","key":"10.1016\/j.jcf.2019.08.010_bb0255","article-title":"Recombinant growth hormone therapy for cystic fibrosis in children and young adults","author":"Thaker","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.jcf.2019.08.010_bb0260","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1210\/jc.2006-1101","article-title":"Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial","volume":"91","author":"Hardin","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jcf.2019.08.010_bb0265","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1067\/mpd.2001.117578","article-title":"Growth hormone improves clinical status in prepubertal children with cystic fibrosis: results of a randomized controlled trial","volume":"139","author":"Hardin","year":"2001","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.010_bb0270","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jpeds.2004.10.037","article-title":"Growth hormone treatment enhances nutrition and growth in children with cystic fibrosis receiving enteral nutrition","volume":"146","author":"Hardin","year":"2005","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.010_bb0275","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ppul.21546","article-title":"A multi-center controlled trial of growth hormone treatment in children with cystic fibrosis","volume":"47","author":"Stalvey","year":"2012","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.jcf.2019.08.010_bb0280","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1249\/00005768-200204000-00001","article-title":"Effect of growth hormone on exercise tolerance in children with cystic fibrosis","volume":"34","author":"Hutler","year":"2002","journal-title":"Med Sci Sports Exerc"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.010_bb0285","doi-asserted-by":"crossref","first-page":"e1230","DOI":"10.1542\/peds.2006-2783","article-title":"German cystic fibrosis growth hormone study G. a multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis","volume":"119","author":"Schnabel","year":"2007","journal-title":"Pediatrics."},{"issue":"12","key":"10.1016\/j.jcf.2019.08.010_bb0290","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/adc.88.12.1078","article-title":"Prospective randomised treatment with recombinant human growth hormone in cystic fibrosis","volume":"88","author":"Schibler","year":"2003","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1016\/j.jcf.2019.08.010_bb0295","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1515\/JPEM.2005.18.6.589","article-title":"Growth hormone improves bone mineral content in children with cystic fibrosis","volume":"18","author":"Hardin","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.010_bb0300","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1515\/JPEM.2006.19.3.237","article-title":"Growth hormone normalizes pubertal onset in children with cystic fibrosis","volume":"19","author":"Vanderwel","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jcf.2019.08.010_bb0305","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13633-015-0013-3","article-title":"Effect of oxandrolone therapy on adult height in turner syndrome patients treated with growth hormone: a meta-analysis","volume":"2015","author":"Sheanon","year":"2015","journal-title":"Int J Pediatr Endocrinol"},{"key":"10.1016\/j.jcf.2019.08.010_bb0310","doi-asserted-by":"crossref","DOI":"10.1186\/1687-9856-2009-826895","article-title":"Oxandrolone improves height velocity and BMI in patients with cystic fibrosis","volume":"2009","author":"Varness","year":"2009","journal-title":"Int J Pediatr Endocrinol."},{"issue":"5","key":"10.1016\/j.jcf.2019.08.010_bb0315","first-page":"576","article-title":"Effect of insulinlike growth factor-1 treatment in children with cystic fibrosis","volume":"33","author":"Bucuvalas","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"10.1016\/j.jcf.2019.08.010_bb0320","article-title":"Appetite stimulants for people with cystic fibrosis","author":"Chinuck","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"7\u20138","key":"10.1016\/j.jcf.2019.08.010_bb0325","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1345\/aph.1R076","article-title":"Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment","volume":"46","author":"Pettit","year":"2012","journal-title":"Ann Pharmacother"},{"issue":"11","key":"10.1016\/j.jcf.2019.08.010_bb0330","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S2213-2600(14)70218-8","article-title":"Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)","volume":"2","author":"McKone","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"11","key":"10.1016\/j.jcf.2019.08.010_bb0335","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1164\/rccm.201301-0153OC","article-title":"Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation","volume":"187","author":"Davies","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2019.08.010_bb0340","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jpeds.2018.05.018","article-title":"Energy balance and mechanisms of weight gain with Ivacaftor treatment of cystic fibrosis gating mutations","volume":"201","author":"Stallings","year":"2018","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.jcf.2019.08.010_bb0345","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2522","article-title":"Growth in Prepubertal children with cystic fibrosis treated with Ivacaftor","volume":"139","author":"Stalvey","year":"2017","journal-title":"Pediatrics."},{"issue":"127","key":"10.1016\/j.jcf.2019.08.010_bb0370","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1183\/09059180.00008512","article-title":"Ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation","volume":"22","author":"Sermet-Gaudelus","year":"2013","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jcf.2019.08.010_bb0375","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000439333","article-title":"Long-acting growth hormone: an update","volume":"30","author":"Saenger","year":"2016","journal-title":"Endocr Dev"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.010_bb0380","first-page":"264","article-title":"Randomized, double-blind, placebo-controlled pilot trial of megestrol acetate in malnourished children with cystic fibrosis","volume":"31","author":"Marchand","year":"2000","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.jcf.2019.08.010_bb0385","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1067\/mpd.2002.121936","article-title":"Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis","volume":"140","author":"Eubanks","year":"2002","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.010_bb0390","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ppul.20265","article-title":"Long-term trial of cyproheptadine as an appetite stimulant in cystic fibrosis","volume":"40","author":"Homnick","year":"2005","journal-title":"Pediatr Pulmonol"},{"issue":"Suppl. 25","key":"10.1016\/j.jcf.2019.08.010_bb0395","first-page":"343","article-title":"Dronabinol, an effective and safe appetite stimulant in cystic fibrosis","volume":"36","author":"Anstead","year":"2003","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.jcf.2019.08.010_bb0400","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ppul.20766","article-title":"Appetite stimulants use in cystic fibrosis","volume":"43","author":"Nasr","year":"2008","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2019.08.010_bb0405","first-page":"326","article-title":"The role of mirtazapine as an appetite sitmulant in malnourished individiuals with","volume":"20","author":"Young","year":"2000","journal-title":"CF Pediatr Pulmonol"},{"issue":"11","key":"10.1016\/j.jcf.2019.08.010_bb0410","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1080\/14740338.2017.1372419","article-title":"The safety of lumacaftor and ivacaftor for the treatment of cystic fibrosis","volume":"16","author":"Talamo Guevara","year":"2017","journal-title":"Expert Opin Drug Saf"},{"issue":"S2","key":"10.1016\/j.jcf.2019.08.010_bb0411","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.jcf.2019.08.013","article-title":"Puberty in cystic fibrosis","volume":"18","author":"Goldsweig","year":"2019","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199319308422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199319308422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:41:18Z","timestamp":1761601278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199319308422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":79,"alternative-id":["S1569199319308422"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2019.08.010","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth failure and treatment in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2019.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}